Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats

<div>Effect of berberine treatment on serum cholesterol, LDL and brain tissue AChE, A<i>β</i><sub>40</sub>, A<i>β</i><sub>42</sub>, and IDE. C: control group, BC: berberine control group, NASH: the CCL<sub>4</sub>-NASH induced group, and Bt: the CCl<sub>4</sub>-NASH induced group treated with berberine. Control group (gray bars), berberine control group (white bars), NASH induced group (black bars), and NASH induced group treated with berberine (dotted gray bars).</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats 